Black Rock Inc. Capricor Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,628,550 shares of CAPR stock, worth $18.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,628,550

Previous 381,735 326.62%

Holding current value

$18.7 Million

Previous $2.59 Million 199.81%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.63 - $7.09 $5.77 Million - $8.84 Million	1,246,815 Added 326.62%	1,628,550 $7.77 Million
Q1 2024 May 10, 2024	BUY	$3.61 - $6.88 $79,643 - $151,786	22,062 Added 6.13%	381,735 $2.59 Million
Q4 2023 Feb 13, 2024	BUY	$2.71 - $5.08 $2,978 - $5,582	1,099 Added 0.31%	359,673 $1.76 Million
Q3 2023 Nov 13, 2023	SELL	$3.42 - $7.85 $179,026 - $410,923	-52,347 Reduced 12.74%	358,574 $1.23 Million
Q2 2023 Aug 11, 2023	BUY	$3.76 - $5.05 $63,698 - $85,552	16,941 Added 4.3%	410,921 $1.96 Million
Q1 2023 May 12, 2023	SELL	$3.78 - $5.03 $169,835 - $225,997	-44,930 Reduced 10.24%	393,980 $1.66 Million
Q4 2022 Feb 13, 2023	BUY	$3.36 - $6.55 $5,651 - $11,017	1,682 Added 0.38%	438,910 $1.69 Million
Q3 2022 Nov 14, 2022	BUY	$3.61 - $6.08 $499,432 - $841,149	138,347 Added 46.29%	437,228 $2.62 Million
Q2 2022 Aug 12, 2022	SELL	$2.89 - $4.51 $10,513 - $16,407	-3,638 Reduced 1.2%	298,881 $1.04 Million
Q1 2022 May 12, 2022	SELL	$2.83 - $5.68 $1,315 - $2,641	-465 Reduced 0.15%	302,519 $1.04 Million
Q4 2021 Feb 10, 2022	BUY	$2.89 - $4.16 $8,042 - $11,577	2,783 Added 0.93%	302,984 $888,000
Q3 2021 Nov 09, 2021	SELL	$3.8 - $5.23 $18,399 - $25,323	-4,842 Reduced 1.59%	300,201 $1.21 Million
Q2 2021 Aug 11, 2021	BUY	$3.16 - $5.72 $963,935 - $1.74 Million	305,043 New	305,043 $1.56 Million

Others Institutions Holding CAPR

# of Institutions

132

Shares Held

15.9M

Call Options Held

1.73M

Put Options Held

1.71M

View Full List

About CAPRICOR THERAPEUTICS, INC.

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $280M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

More about CAPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account